Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 July 2020 | Story Thabo Kessah | Photo Charl Devenish
The handover was done by Thomas September, ABSA Head Regional Coverage: Relationship Banking. With him are a student, Emily Ndlovu, Ntokozo Nkabinde (Institutional Advancement) and Tshenolo Thibeletsa (ICT).

“I am still in disbelief. Before I had this laptop, I was borrowing my cousin's laptop to do my academic tasks.”

These are the words of final-year Biochemistry and Food Science student, Xoliswa Khumalo, one of 200 students who recently became recipients of a generous donation of laptops from ABSA. In its endeavour to make a contribution towards saving the 2020 academic year, ABSA identified deserving students.

Xoliswa continued: “This laptop will help me type my assignments, since all of them need to be typed. I will also be able to view my slides and watch videos of my lectures. Now I do not have to wait for my cousin to watch movies. I am free to use mine for as long as I want.”

Another recipient is Itumeleng Katjedi, a second-year Economics student. “Thank you very much for the contribution to making my education journey much easier and simpler. I will be sure to strive to get the best grades,” she said.

“The University of the Free State (UFS) wishes to express its sincere appreciation to ABSA for investing in the future of those students who have little or no financial means to complete their studies remotely.  Much has changed and many lives are directly and indirectly affected by the COVID-19 pandemic,” says Rector and Vice-Chancellor, Prof Francis Petersen, in a letter to ABSA’s Dr Reaan Immelman, Head: Education Delivery Citizenship.  

“These are challenging times, not only for our country, but also for higher education institutions, as we work towards ensuring that the academic year is completed without any of our students being left behind.  The UFS is deeply thankful for the 200 laptops, which will make an immeasurable contribution to alleviating inequalities between the different student cohorts.  For these students, this gesture will not only advance their academic success; it will position them for the future world of work. ABSA will always be remembered as the co-creator of their future,” he adds in the letter.

Students from across the length and breadth of South Africa continue to receive their laptops via courier services, and those near the campuses are able to collect them while observing the COVID-19 regulations.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept